INFI - Infinity Pharmaceuticals Stock Trading

Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced ...

Clinical-stage biotech Infinity Pharmaceuticals (NASDAQ: INFI) had a big and bright Monday, with its stock closing the session more than 38% higher. The rocket that lifted it was ignited by a prominent investment bank's upgrade, the latest in a series of analyst upgrades for the stock. ...

3 Robinhood Penny Stocks For Your August Watchlist Today, both penny stocks and blue chips climbed as a new month set in, and fears of the new Covid wave subsided. While the Delta variant is still surging, investors seem confident in the direction of the economy right now. Today’...